Navigation Links
Drug-Resistant TB Declines in United States
Date:11/11/2008

Number of XDR-TB cases down to only 2 in 2007, CDC reports

TUESDAY, Nov. 11 (HealthDay News) -- Running contrary to what is occurring elsewhere in the world, the number of drug-resistant tuberculosis cases in the United States has declined dramatically in the past 15 years. But U.S. government officials caution that the more than 13,000 other cases of TB in America in 2007 need to be reduced as well.

TB is the leading cause of infectious disease death among adults worldwide, and drug-resistant TB (which includes multidrug-resistant TB and XDR-TB) is an increasing threat, with an estimated 489,000 new cases in 2006.

In this study, researchers from the U.S. Centers for Disease Control and Prevention analyzed 15 years of U.S. surveillance data from 1993 to 2007 and found that 83 cases of XDR-TB were reported during that time. The number of XDR-TB cases per year declined from 18 (0.07 percent of 25,107 TB cases) in 1993 to two (0.02 percent of 13,293 TB cases) in 2007.

Of the 40 XDR-TB cases reported from 1993 to 1997, 25 (62 percent) were in HIV-infected patients, compared with six of 43 cases (14 percent) reported in 2007.

Of the 83 XDR-TB cases reported in the United States from 1993 to 2007, most patients were ages 25 to 44, male (64 percent), U.S.-born, and unemployed (53 percent). There were 33 Hispanic patients (44 percent), and three cases occurred among health-care workers. Compared with drug-treatable TB cases, patients with XDR-TB were more likely to be Hispanic and correctional facility inmates.

The study also found that 26 XDR-TB patients (35 percent) died during treatment. Of those, 21 (81 percent) had HIV. Death rates for XDR-TB patients were nearly two times higher than among MDR-TB patients and more than six times higher than among drug-treatable TB patients. HIV was a major factor in both the occurrence and outcomes of XDR-TB cases, the researchers said.

"Preventing the further emergence of drug resistance is paramount and must include not only TB program strengthening to ensure that patients complete their treatment regimen but also general health system interventions to improve infection control. Greater vigilance regarding drug resistance must include systematic second-line drug susceptibility testing according to published guidelines. Lessons gained from MDR-TB in the 1990s should be applied: Patients must be identified early, treated effectively, and assisted to complete treatment, and infection control precautions must be in place to prevent further emergence and transmission of XDR-TB," the researchers concluded.

The study was published in the Nov. 12 issue of the Journal of the American Medical Association.

More information

The U.S. Centers for Disease Control and Prevention has more about drug-resistant XDR-TB.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Nov. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
2. Ear Infections Linked to Drug-Resistant Superbug
3. Drug-Resistant Staph a Widespread Threat
4. Drug-Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U.S.
5. APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene
6. The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
7. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
8. Symposium on drug-resistant diseases set for annual AAAS conference
9. Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs
10. NIAID describes research priorities to fight drug-resistant tuberculosis
11. Extensively drug-resistant tuberculosis found in California
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug-Resistant TB Declines in United States
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: